Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice
- 6 March 2012
- journal article
- research article
- Published by Taylor & Francis in Experimental Lung Research
- Vol. 38 (3) , 135-146
Abstract
In addition to parenchymal fibrosis, fibrotic remodeling of the distal airways has been reported in interstitial lung diseases. Mechanisms of airway wall remodeling, which occurs in a variety of chronic lung diseases, are not well defined and current animal models are limited. The authors quantified airway remodeling in lung sections from subjects with idiopathic pulmonary fibrosis (IPF) and controls. To investigate intratracheal bleomycin as a potential animal model for fibrotic airway remodeling, the authors evaluated lungs from C57BL/6 mice after bleomycin treatment by histologic scoring for fibrosis and peribronchial inflammation, morphometric evaluation of subepithelial connective tissue volume density, TUNEL (terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling) assay, and immunohistochemistry for transforming growth factor β1 (TGFβ1), TGFβ2, and the fibroblast marker S100A4. Lung mechanics were determined at 3 weeks post bleomycin. IPF lungs had small airway remodeling with increased bronchial wall thickness compared to controls. Similarly, bleomycin-treated mice developed dose-dependent airway wall inflammation and fibrosis and greater airflow resistance after high-dose bleomycin. Increased TUNEL+ bronchial epithelial cells and peribronchial inflammation were noted by 1 week, and expression of TGFβ1 and TGFβ2 and accumulation of S100A4+ fibroblasts correlated with airway remodeling in a bleomycin dose–dependent fashion. IPF is characterized by small airway remodeling in addition to parenchymal fibrosis, a pattern also seen with intratracheal bleomycin. Bronchial remodeling from intratracheal bleomycin follows a cascade of events including epithelial cell injury, airway inflammation, profibrotic cytokine expression, fibroblast accumulation, and peribronchial fibrosis. Thus, this model can be utilized to investigate mechanisms of airway remodeling.Keywords
This publication has 44 references indexed in Scilit:
- Bronchial Secretory Immunoglobulin A Deficiency Correlates With Airway Inflammation and Progression of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2011
- The role of small airways in obstructive airway diseasesEuropean Respiratory Review, 2011
- Airway Epithelial Cells: Current Concepts and ChallengesProceedings of the American Thoracic Society, 2008
- Characterization of Fibroblast-specific Protein 1 in Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Variability of Interalveolar Septal Remodeling After Bleomycin Treatment in MiceUltrastructural Pathology, 2005
- Airway Remodeling in AsthmaChest, 2003
- Small airway involvement in interstitial lung disease: radiologic evidenceCurrent Opinion in Pulmonary Medicine, 2000
- Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus StatementAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Staining apoptosis in paraffin sections. Advantages and limits.1999
- Identification and characterization of a fibroblast marker: FSP1.Journal of Cell Biology, 1995